Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection.

Objectives: In this study, we estimate an ex ante cost-benefit analysis of a Utah law directed at improving early cytomegalovirus (CMV) detection.

Study Design: We use a differential cost of treatment analysis for publicly insured CMV-infected infants detected by a statewide hearing-directed CMV screening program.

Methods: Utah government administrative data and multi-hospital accounting data are used to estimate and compare costs and benefits for the Utah infant population.